Subscriptions are live: We're on the subscription model now, early-access price $24.99/month, with day, week, and longer plans too. New accounts start with 5 free premium days. Prefer to donate? Donations grant premium time and are logged on your profile page.

$ARQT

Arcutis Biotherapeutics, Inc. Common Stock

XNAS

$26.77-1.22%$0.3300Prev $27.10LIVE Full chart Live alerts
No recent price bars, the chart lights up when ARQT starts printing.

Why is ARQT down today? It is at $26.77 (-1.22%), and our scanner flagged it 22 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ARQT spikes, and full due diligence on ARQT — key stats, earnings, dilution and insider activity. Free.

Free alerts

Get free $ARQT alerts the moment volume spikes

Our scanner flagged $ARQT 22 times in the last 30 days. Create a free account to track $ARQT, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Key Stats

Price & performance
Price
$26.77
Change today
-1.22%
Previous close
$27.10
52-week range
$13.70 – $31.77
Valuation & dividend
Market cap
$3.41B
Ownership & volume
Shares outstanding
125.7M
SEC · as of 2026-07-31 · 6d
Insider ownership
7.8%
DEF 14A · 2026-04-21
Institutional own.
99.9%
Total held
100.0%
Short interest
13.6M
▼ -3% vs prior · as of 2026-07-15
Days to cover
9.3d
Avg daily volume
1.8M
Classification
Exchange
XNAS
Relative volumevs this time of day
5m
2.7x
15m
3.0x
1h
2.6x
1D
0.3x

Get free ARQT + market alerts in your inbox

The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.

No spam. Unsubscribe anytime. Not investment advice.

Why is $ARQT down today?

5 alerts today16.8x RVOLSEC filing

ARQT is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 5 unusual-volume and momentum alerts on ARQT today, peaking at 16.8x its normal volume. Fresh from the SEC: Arcutis Biotherapeutics, Inc. filed a Quarterly report (10-Q). A material company disclosure like this is often the real catalyst behind a move of this size.

Likely catalystQuarterly report (10-Q), from the latest SEC filing. Read it →
Why is $ARQT moving? →▶ Replay the moveAuto-generated from live scanner data. Not investment advice.
Trading profile⚡ Ultra-low floatShortableEasy to borrowNo SSRBorrow via Alpaca · SSR from Reg SHO 201
Wall Street consensusStrong Buy6 analysts
Avg target $36.57(+37% upside)
Range $34 – $40
6 buy0 hold0 sell

Analyst data via Nasdaq. Not investment advice.

Insiders

Insiders buying9 buys, 6 sells last 3 months (15/63 over 12 months)
Show 12 recent transactions
InsiderActionShares% of positionOwns afterValueDate
Welgus Howard G.
Director
Sold (automatic/other)-5Ksold 11%37K$127K
at $26.91
Jul 15, 26
Welgus Howard G.
Director
Other4Kadded 11%42K$27K
at $6.52
Jul 15, 26
Peetz Christopher
Director
Acquired (grant/award)+4Kn/a4Kn/aJul 15, 26
Welgus Howard G.
Director
Sold (automatic/other)-635sold 1.7%38K$16K
at $25.67
Jun 17, 26
Welgus Howard G.
Director
Sold (automatic/other)-4Ksold 9.6%38K$100K
at $24.41
Jun 15, 26
Welgus Howard G.
Director
Other4Kadded 11%42K$27K
at $6.52
Jun 15, 26
Lin Sue-Jean
Director
Sold (automatic/other)-5Ksold 15%28K$121K
at $24.38
Jun 15, 26
Gilbert Halley E
Director
Acquired (grant/award)+6Kadded 26%28Kn/aJun 5, 26
Krishnamohan Neha
Director
Acquired (grant/award)+6Kadded 26%28Kn/aJun 5, 26
Munshi Amit
Director
Acquired (grant/award)+6Kadded 100%10Kn/aJun 5, 26
Curran Terrie
Director
Acquired (grant/award)+6Kadded 33%24Kn/aJun 5, 26
Leonard Keith R
Director
Acquired (grant/award)+6Kadded 26%28Kn/aJun 5, 26

Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.

$ARQT Sentiment

Bullish
Bearish75Bullish
📰 News: 4 bull · 0 bearToday: -1.2%👥 Community: 0 bull · 0 bear

Blend of news sentiment, today’s move, and community votes. Not investment advice.

$ARQT Activity

News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.

Alert· 8m ago 16.8× RVOL
ARQT hit 16.777x RVOL at 11:20 AM ET
at $26.72
Alert· 17m ago -1.33%
$ARQT moved -1.33% in 1 min (Level 1) at 11:11 AM ET
at $27.00
Alert· 17m ago 5.5× RVOL
ARQT hit 5.475x RVOL at 11:11 AM ET
at $27.04
News· The Motley Fool· 3h ago Bullish
Arcutis President and CEO Todd Watanabe Sells 4,375 Shares for $114,275 as Q2 Results Demonstrate Profitability
Alert· 3h ago -1.17%
$ARQT moved -1.17% in 1 min (Level 1) at 8:25 AM ET
at $28.27
Alert· 6h ago +3.29%
$ARQT moved +3.29% in 1 min (Level 3) at 5:24 AM ET
at $30.74
Alert· 17h ago +7.2% vs EMA
ARQT 200EMA (1m) Trending · 50 bars · L3 · +7.21% above EMA · slope +1.65%
at $29.87
Alert· 17h ago +1.7% vs EMA
ARQT 50EMA (1m) Trending · 50 bars · L3 · +1.68% above EMA · slope +2.23%
at $29.87
News· SEC EDGAR· 19h ago
Arcutis Biotherapeutics, Inc. filed a Quarterly report (10-Q)
News· SEC EDGAR· 19h ago
Arcutis Biotherapeutics, Inc.: Arcutis Announces Second Quarter 2026 Financial Results and Provides Business Update
Alert· 19h ago +1.66%
$ARQT moved +1.66% in 1 min (Level 1) at 4:02 PM ET
at $30.00
Alert· 20h ago 4.3× RVOL
ARQT hit 4.338x RVOL at 3:22 PM ET
at $26.45
Alert· 22h ago +1.3% vs EMA
$ARQT near 200 EMA: +1.34% from 200 EMA at 1:21 PM ET
at $26.95
Alert· 22h ago 11.4× RVOL
ARQT hit 11.361x RVOL at 1:21 PM ET
at $26.95
Alert· 23h ago +0.3% vs EMA
$ARQT near 200 EMA: +0.25% from 200 EMA at 11:30 AM ET
at $26.55
Alert· 23h ago 13.1× RVOL
ARQT hit 13.127x RVOL at 11:30 AM ET
at $26.55
Alert· 1d ago 7.1× RVOL
ARQT hit 7.078x RVOL at 10:48 AM ET
at $26.56
Alert· 1d ago 10.6× RVOL
ARQT hit 10.631x RVOL at 1:27 PM ET
at $26.04
Alert· 2d ago 12.9× RVOL
ARQT hit 12.918x RVOL at 2:59 PM ET
at $25.63
Alert· 2d ago -1.7% vs EMA
$ARQT near 200 EMA: -1.66% from 200 EMA at 2:43 PM ET
at $25.70
Alert· 2d ago +1.08%
$ARQT moved +1.08% in 1 min (Level 1) at 2:43 PM ET
at $25.70
Alert· 2d ago 2.5× RVOL
ARQT hit 2.445x RVOL at 2:43 PM ET
at $25.70
Alert· 2d ago 10.8× RVOL
ARQT hit 10.781x RVOL at 11:34 AM ET
at $26.03
Alert· 5d ago -2.3% vs EMA
$ARQT near 200 EMA: -2.30% from 200 EMA at 12:16 PM ET
at $26.35
Alert· 5d ago 5.2× RVOL
ARQT hit 5.228x RVOL at 12:16 PM ET
at $26.35
Alert· 5d ago -2.3% vs EMA
$ARQT near 200 EMA: -2.34% from 200 EMA at 11:45 AM ET
at $26.47
Alert· 5d ago 9.8× RVOL
ARQT hit 9.752x RVOL at 11:45 AM ET
at $26.47
Alert· 6d ago 2.7× RVOL
ARQT hit 2.725x RVOL at 11:03 AM ET
at $26.63
News· SEC EDGAR· 20d ago
Arcutis Biotherapeutics, Inc. filed an 8-K: Executive / Board Change, Regulation FD Disclosure
News· GlobeNewswire Inc.· 21d ago Bullish
Arcutis Expands Board of Directors with Appointment of Chris Peetz
News· GlobeNewswire Inc.· 37d ago Bullish
FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children as Young as Age 2
News· The Motley Fool· 43d ago Bullish
Arcutis Director Sells $121,000 in Stock as ZORYVE Revenue Jumps 65%
News· SEC EDGAR· 57d ago
Arcutis Biotherapeutics, Inc. filed an 8-K: Shareholder Vote, Other Material Event

Also moving today

The tickers our scanner is lighting up most over the last 48 hours.

ARQT stock FAQ

Why is $ARQT down today?

ARQT is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 5 unusual-volume and momentum alerts on ARQT today, peaking at 16.8x its normal volume. Fresh from the SEC: Arcutis Biotherapeutics, Inc. filed a Quarterly report (10-Q). A material company disclosure like this is often the real catalyst behind a move of this size.

What is the ARQT stock price today?

ARQT last traded at $26.77, down 1.22% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).

Where can I see live ARQT alerts?

The ARQT Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ARQT 22 times in the last 30 days.

What exchange is ARQT on?

ARQT (Arcutis Biotherapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $3.41B.

Is ARQT good for day trading?

That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ARQT for yourself. This is not investment advice.

Live data from TheDesperateTrader scanner. Not investment advice.